相关实验视频
Updated: Sep 18, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.5K
安德罗格拉福利德对OVA刺激小鼠通过Th17细胞分化介导的糖解路径产生抗喘作用
Qian Yu1, XuChun Ding1, ChunXiu Xu2
1Department of Pulmonary and Critical Care Medicine, Hangzhou TCM Hospital affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Archives of biochemistry and biophysics
|June 20, 2025
概括
安德罗格拉福利德 (AG) 通过阻断糖解和Th17细胞分化来抑制喘. 这项研究探讨了AG AG.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘仍然是一个重要的全球健康问题,尽管存在治疗方法,但喘的恶化和死亡率很高.
- 安德罗格拉福利德 (AG),来自Andrographis paniculate,通过各种机制表现出抗喘性质.
- 之前还没有研究过AG通过糖解路径调节喘的作用.
研究的目的:
- 研究Andrographolide (AG) 通过调节糖解路径来抑制喘的潜在作用和潜在机制.
- 在喘模型中探索AG对关键糖解酶和炎症标记物的影响.
主要方法:
- 在动物中建立卵胺 (OVA) 诱导的喘模型.
- 使用ELISA,rt-PCR和西白斑的方法分析支气管洗液 (BALF),血清和肺组织.
- 网络药理和流细胞计的应用,以通过糖溶解识别和验证AG在喘治疗中的目标.
主要成果:
- AG治疗降低了肺组织中关键的糖解酶 (HK2,PKM2,LDHA) 和乳酸的水平.
- 在mRNA和蛋白质水平上,AG抑制了OVA诱导的Glut-1,LDHA和PKM2的表达.
- 网络药理学确定IL-1β和Th17细胞分化作为潜在的目标被AG抑制,以及降低IL-17水平.
结论:
- 安德罗格拉福利德 (AG) 在喘小鼠模型中有效抑制炎症反应.
- AG通过抑制糖解路径的激活来发挥其抗喘作用.
- 该机制涉及准Th17细胞分化,这表明了喘的新型治疗方法.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484
01:24Antiasthma Drugs: Methylxanthines
419
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
419
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
404
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
404
01:19Antiasthma Drugs: Leukotriene Modifiers
502
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
502
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
477
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
477
01:20Asthma: Pathogenesis and Management
618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618